Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 67 Records) |
| Query Trace: Polycythemia Vera and CALR[original query] |
|---|
| Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia. Hematology reports 2022 Aug 14 (3): 265-269. Santoro Marco, Accurso Vincenzo, Mancuso Salvatrice, Napolitano Mariasanta, Mattana Marta, Vajana Giorgia, Russello Federica, Siragusa Serg |
| [Detection and Diagnostic Values of JAK2, CALR, MPL Gene Mutations in 208 Cases of BCR/ABL1 Negative Chronic Myeloproliferative Diseases]. Zhongguo shi yan xue ye xue za zhi 2018 Aug 26 (4): 1122-1128. Li Zhen-Ling, Gao Li, Zhang Hui, Zhang Chun-Xia, Chen Yan-Rong, Huang Fan-Zhou, Gong Ming, Gao Ya-Yue, Tang Yin, Ma Yi-G |
| Classification and Personalized Prognosis in Myeloproliferative Neoplasms. The New England journal of medicine 2018 10 379 (15): 1416-1430. Grinfeld Jacob, Nangalia Jyoti, Baxter E Joanna, Wedge David C, Angelopoulos Nicos, Cantrill Robert, Godfrey Anna L, Papaemmanuil Elli, Gundem Gunes, MacLean Cathy, Cook Julia, O'Neil Laura, O'Meara Sarah, Teague Jon W, Butler Adam P, Massie Charlie E, Williams Nicholas, Nice Francesca L, Andersen Christen L, Hasselbalch Hans C, Guglielmelli Paola, McMullin Mary F, Vannucchi Alessandro M, Harrison Claire N, Gerstung Moritz, Green Anthony R, Campbell Peter |
| Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea. Blood 2019 9 134 (18): 1498-1509. Yacoub Abdulraheem, Mascarenhas John, Kosiorek Heidi, Prchal Josef T, Berenzon Dmitry, Baer Maria R, Ritchie Ellen, Silver Richard T, Kessler Craig, Winton Elliott, Finazzi Maria Chiara, Rambaldi Alessandro, Vannucchi Alessandro M, Leibowitz David, Rondelli Damiano, Arcasoy Murat O, Catchatourian Rosalind, Vadakara Joseph, Rosti Vittorio, Hexner Elizabeth, Kremyanskaya Marina, Sandy Lonette, Tripodi Joseph, Najfeld Vesna, Farnoud Noushin, Papaemmanuil Elli, Salama Mohamed, Singer-Weinberg Rona, Rampal Raajit, Goldberg Judith D, Barbui Tiziano, Mesa Ruben, Dueck Amylou C, Hoffman Rona |
| Targeted molecular characterization shows differences between primary and secondary myelofibrosis. Genes, chromosomes & cancer 2019 7 59 (1): 30-39. Courtier Frédéric, Garnier Séverine, Carbuccia Nadine, Guille Arnaud, Adélaide José, Chaffanet Max, Hirsch Pierre, Paz Damien Luque, Slama Bohrane, Vey Norbert, Ugo Valérie, Delhommeau François, Rey Jérome, Birnbaum Daniel, Murati An |
| Rapid, low cost and sensitive detection of Calreticulin mutations by a PCR based amplicon length differentiation assay for diagnosis of myeloproliferative neoplasms. BMC medical genetics 2019 6 20 (1): 115. Trung Ngo Tat, Quyen Dao Thanh, Hoan Nghiem Xuan, Giang Dao Phuong, Trang Tran Thi Huyen, Velavan Thirumalaisamy P, Bang Mai Hong, Song Le H |
| Systematization of analytical studies of polycythemia vera, essential thrombocythemia and primary myelofibrosis, and a meta-analysis of the frequency of JAK2, CALR and MPL mutations: 2000-2018. BMC cancer 2019 6 19 (1): 590. Mejía-Ochoa Mónica, Acevedo Toro Paola Andrea, Cardona-Arias Jaiberth Anton |
| Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation. Blood 2019 2 133 (20): 2233-2242. Gagelmann Nico, Ditschkowski Markus, Bogdanov Rashit, Bredin Swann, Robin Marie, Cassinat Bruno, Shahswar Rabia, Thol Felicitas, Heuser Michael, Socié Gerard, Beelen Dietrich, Triviai Ioanna, Badbaran Anita, Kröger Nicola |
| [The genetic characteristics of BCR-ABL-negative myeloproliferative neoplasms]. Zhonghua nei ke za zhi 2019 12 59 (1): 35-39. Lyu X D, Li Y W, Guo Z, Xin Y P, Hu J Y, Fan R H, Song Y |
| Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms. Hematology, transfusion and cell therapy 2019 Oct . Porto-Soares Moysés Antonio, de Oliveira Rafael Daltro, Cortopassi Gabriel Macedo, Machado-Neto João Agostinho, Palma Leonardo Carvalho, Figueiredo-Pontes Lorena Lobo |
| Mutational profiling in myelofibrosis: implications for management. International journal of hematology 2019 10 111 (2): 192-199. Bose Prithviraj, Verstovsek Srd |
| TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative neoplasms in Japanese patients. International journal of hematology 2019 Sep . Matsuguma Masafumi, Yujiri Toshiaki, Yamamoto Kaoru, Kajimura Yasuko, Tokunaga Yoshihiro, Tanaka Mayumi, Tanaka Yoshinori, Nakamura Yukinori, Tanizawa Yuk |
| WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis. Blood cells, molecules & diseases 2019 1 75 35-40. Cottin Laurane, Riou Jérémie, Boyer Françoise, Bouvier Anne, Zannetti Alain, Blouet Anaïse, Truchan-Graczyk Matgorzata, Jouanneau-Courville Rébecca, Beucher Annaëlle, Ribourtout Bénédicte, Orvain Corentin, Hunault-Berger Mathilde, Blanchet Odile, Ugo Valérie, Luque Paz Dami |
| [Analysis of gene mutations and clinic features in 108 patients with myeloproliferative neoplasm]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2020 8 41 (7): 576-582. Tan Y X, Xu N, Huang J X, Wu W E, Liu L, Zhou L L, Liu X L, Yin C X, Xu D, Zhou |
| JAK2, CALR, and MPL Mutations in Egyptian Patients With Classic Philadelphia-negative Myeloproliferative Neoplasms. Clinical lymphoma, myeloma & leukemia 2020 6 20 (10): e645-e651. Soliman Eman A, El-Ghlban Samah, El-Aziz Sherin Abd, Abdelaleem Abdelaleem, Shamaa Sameh, Abdel-Ghaffar Hass |
| miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk. Leukemia 2020 2 34 (10): 2648-2659. Ferrer-Marín F, Arroyo A B, Bellosillo B, Cuenca E J, Zamora L, Hernández-Rivas J M, Hernández-Boluda J C, Fernandez-Rodriguez C, Luño E, García Hernandez C, Kerguelen A, Fiallo-Suárez D V, Gómez-Casares M T, Ayala R, Vélez P, Boqué C, García-Gutierrez V, Arrizabalaga B, Estrada N, Cifuentes R, Arcas I, de Los Reyes-García A M, Besses C, Vicente V, Alvarez-Larrán A, Teruel-Montoya R, González-Conejero R, Martínez C, |
| [Pathological characteristics of megakaryocytes in myeloproliferative neoplasms and their correlation with driver gene mutations]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2020 11 41 (10): 798-805. Shi Z X, Zhang P H, Li B, Fang L H, Xu Z F, Qin T J, Liu J Q, Hu N B, Pan L J, Qu S Q, Liu D, Xiao Z |
| Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN). International journal of environmental research and public health 2021 Jul 18 (14): . Zulkeflee Razan Hayati, Zulkafli Zefarina, Johan Muhammad Farid, Husin Azlan, Islam Md Asiful, Hassan Rosli |
| JAK2, CALR, and MPL Mutation Profiles in BCR-ABL Negative Myeloproliferative Neoplasms, a Referral Center Experience in the Middle East. Iranian journal of pathology 2021 5 16 (2): 190-194. Safavi Moeinadin, Monabati Ahmad, Safaei Akbar, Mirtalebi Maryam Sadat, Faghih Masoum |
| Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era. Journal of clinical medicine 2021 Mar 10 (5): . Lee Jong-Mi, Lee Howon, Eom Ki-Seong, Lee Sung-Eun, Kim Myungshin, Kim Yongg |
| Analysis of Common Driver Mutations in Philadelphia-Negative Myeloproliferative Neoplasms. Clinical lymphoma, myeloma & leukemia 2021 4 21 (7): 483-488. Alshemmari Salem H, Rajan Reshmi, Ameen Reem, Almazyad Mazy |
| Mutation Profile in BCR-ABL1-Negative Myeloproliferative Neoplasms: A Single-Center Experience From India. Hematology/oncology and stem cell therapy 2021 3 15 (2): 13-20. Maddali Madhavi, Kulkarni Uday Prakash, Ravindra Niveditha, Arunachalam Arun Kumar, Venkatraman Arvind, Lionel Sharon, Manipadam Marie Therese, Devasia Anup J, Korula Anu, Fouzia N A, Abraham Aby, Srivastava Alok, George Biju, Balasubramanian Poonkuzhali, Mathews Vikr |
| Clinical and Molecular Attributes of Patients With BCR/ABL1-negative Myeloproliferative Neoplasms in India: Real-world Data and Challenges. Clinical lymphoma, myeloma & leukemia 2021 3 21 (6): e569-e578. Singh Suvir, Kaur Komalpreet, Paul Davinder, Jain Kunal, Singh Jagdeep, Narang Vikram, Garg Bhavna, Sood Neena, Dhillon Barjinderj |
| von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well-controlled platelet counts. European journal of haematology 2022 9 109 (6): 779-786. Iizuka Kazuhide, Morishita Soji, Nishizaki Yuji, Iizuka Yoshikazu, Iriyama Noriyoshi, Ochiai Tomonori, Yanagisawa Naotake, Yasuda Hajime, Ando Jun, Gotoh Akihiko, Takei Masami, Hatta Yoshihiro, Nakamura Hideki, Nakayama Tomohiro, Komatsu Nor |
| The differences of hemogram, myelogram, and driver gene mutations in classic myeloproliferative neoplasms. Blood cells, molecules & diseases 2022 8 97 102698. Wang Jin, Zhang Jin, Huang Jinjin, Mei Yu, Hong Zhen |
| Vascular Endothelial Dysfunction in Myeloproliferative Neoplasms and Gene Mutations. International heart journal 2022 7 63 (4): 661-668. Aoyama Rie, Kubota Yoshiaki, Tara Shuhei, Wakita Satoshi, Yamaguchi Hiroki, Shimizu Wataru, Takano Hitos |
| Lab tests for MPN. International review of cell and molecular biology 2022 2 366 187-220. Moncada Alice, Pancrazzi Alessand |
| Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis. Advances in experimental medicine and biology 2023 4 1408 273-290. Sun?ica Kapor, Sanja Mom?ilovi?, Slobodan Kapor, Slavko Mojsilovi?, Milica Radojkovi?, Milica Apostolovi?, Branka Filipovi?, Mirjana Goti?, Vladan ?oki?, Juan F Santiban |
| Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL. Technology in cancer research & treatment 2023 2 22 15330338231154092. Wang Yan, Ran Fei, Lin Jin, Zhang Jing, Ma D |
| The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience. Cellular and molecular biology (Noisy-le-Grand, France) 2023 2 68 (8): 202-209. Basim Najm Maysam, Jalal Sana Dlawar, Getta Hisham Ar |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 30, 2023
- Content source: